Poseida Thera

$2.02 0.00% ($0.00)

Get ready to invest

About Poseida Thera

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company has discovered and are developing a broad portfolio of product candidates in a variety of indications based on its core platforms, including its non-viral piggyBac deoxyribonucleic acid (DNA) Modification System, Cas-CLOVER site-specific gene editing system and nanoparticle- and adeno-associated virus (AAV)-based gene delivery technologies. The Company’s product candidate portfolio includes P-BCMA-101, P-PSMA-101, P-BCMA-ALLO1, P-MUC1C-ALL01, Dual CAR, P-OTC-101 and P-MMUT-101.

Popular Stocks	Price	Change
Nu Holdings NU	$4.33 13.35%	13.35%
Annaly NLY	$6.27 1.42%	1.42%
AMD AMD	$96.67 0.41%	0.41%
Nvidia NVDA	$171.24 1.1%	1.1%
SoFi Technologies, Inc. SOFI	$7.75 7.19%	7.19%
Ford F	$12.85 0.55%	0.55%
Apple AAPL	$137.35 2.46%	2.46%
Cisco CSCO	$41.72 13.73%	13.73%
Grab Holdings inc. GRAB	$3.14 24.11%	24.11%
NIO NIO	$16.66 5.24%	5.24%